---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-23-000082"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2023-06-13T23:59:59+00:00"
generated_at: "2026-06-14T01:50:32.793211+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Elevance Health reaffirms FY2023 adjusted EPS guidance >$32.70

## Summary
- Net income guidance >$29.50 per share including ~$3.20 net unfavorable items.
- Adjusted net income guidance >$32.70 per share, excluding items from Q1 2023 earnings.
- Company officers to meet with investors over upcoming weeks; reaffirms prior outlook.

## SEC filing metadata
- accession: 0001156039-23-000082
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2023-06-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603923000082/0001156039-23-000082-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603923000082/elv-20230613.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-23-000082
- JSON: https://secwatch.observer/filing/0001156039-23-000082.json
- Plain text: https://secwatch.observer/filing/0001156039-23-000082.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.